Molecular pathology of non-small cell lung cancer: a practical guide.
about
The Utilization of Cytologic Fine-Needle Aspirates of Lung Cancer for Molecular Diagnostic TestingThe Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung CancerDigoxin downregulates NDRG1 and VEGF through the inhibition of HIF-1α under hypoxic conditions in human lung adenocarcinoma A549 cellsPreappointment testing for BRAF/KIT mutation in advanced melanoma: a model in molecular data delivery for individualized medicineCurrent state of immunotherapy for non-small cell lung cancer.The efficacy of EGFR gene mutation testing in various samples from non-small cell lung cancer patients: a multicenter retrospective study.Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population.Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy).Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?Impact of a Contralateral Tumor Nodule on Survival in Non-Small-Cell Lung CancerA targeted next-generation sequencing method for identifying clinically relevant mutation profiles in lung adenocarcinoma.Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics.Comprehensive Genomic Profiling Facilitates Implementation of the National Comprehensive Cancer Network Guidelines for Lung Cancer Biomarker Testing and Identifies Patients Who May Benefit From Enrollment in Mechanism-Driven Clinical Trials.Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.The feasibility of molecular testing on cell blocks created from brush tip washings in the assessment of peripheral lung lesions.Biopsy and mutation detection strategies in non-small cell lung cancer.Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma.Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression.Exome sequencing identifies frequent mutation of MLL2 in non-small cell lung carcinoma from Chinese patients.EGFR analysis: current evidence and future directions.Induction of Activating Transcription Factor 3 Is Associated with Cisplatin Responsiveness in Non-Small Cell Lung Carcinoma Cells.Combined point mutation in KRAS or EGFR genes and EML4-ALK translocation in lung cancer patients.Expression of p114RhoGEF predicts lymph node metastasis and poor survival of squamous-cell lung carcinoma patients.Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.Fluorofenidone Inhibits the Proliferation of Lung Adenocarcinoma CellsCanadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.Targeted next-generation sequencing using fine-needle aspirates from adenocarcinomas of the lung.A panel of four immunohistochemical markers (CK7, CK20, TTF-1, and p63) allows accurate diagnosis of primary and metastatic lung carcinoma on biopsy specimens.Toward personalized medicine of lung cancer: response to nontargeted therapy in invasive pulmonary adenocarcinoma as a function of tumor cell differentiation.Detection of EGFR and KRAS gene mutations using suspension liquid-based cytology specimens in metastatic lung adenocarcinoma.Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland.Marine Bacterial Polysaccharide EPS11 Inhibits Cancer Cell Growth via Blocking Cell Adhesion and Stimulating Anoikis.The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancer.Treatment of Advanced Non-small-Cell Lung Cancer with Qi-Nourishing Essence-Replenishing Chinese Herbal Medicine Combined with Chemotherapy.Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer
P2860
Q26824315-9AA20281-1CC3-4604-9295-2E87B3650108Q28395836-ADAD8E5E-E715-44CF-88C0-0A93040DC8F7Q28397747-680044F4-FDAC-43EB-9CB2-BBDE5C8512CDQ30847040-1DDFD688-3417-4781-8EFD-5057CFD86FEEQ33645595-73F4859A-A6BC-47FA-9151-FD8613C5C0DFQ34809526-FDCE8238-42F9-48C0-82A7-38F7C9F3198EQ35028752-F3256247-3434-4974-BE30-A3C5423AFA99Q35078128-FD605B81-FEA0-4807-AC82-BF5BF65754C5Q35828495-6CE4368C-45EE-47F9-AEE7-0CBBB94FB95EQ35934241-42D45867-84E5-499B-8025-5E076DDD99F2Q36258101-5301346A-131A-45E0-B751-5F381CE5F072Q36645600-B7D89D2D-DC96-41D5-81D4-2F6B42D5A42EQ36998321-26F38B1D-E461-4C92-AAC3-66568C835440Q37017060-E8605D18-A214-47CD-A8AD-FFFC47FE0D3FQ37051546-F1F568A4-D089-4C01-B607-DC3D35ED594AQ37329434-4B091EFF-2B44-4F12-9CFE-F76F723813B5Q37388387-E9DB668B-9267-42D5-B39C-DBFABCB11D86Q37634419-B135766A-6692-4DF7-BFBD-FD8C533F2E93Q37717138-3051514C-C638-4635-8792-07D4D547B822Q37738412-1C50A34E-FA37-458A-928A-9AEA8A147668Q38195265-0A0A8132-7BB1-4EA2-AC58-B798B512FB7AQ38744268-B0F4BBD6-0A74-4ED3-B42E-A03D6441F359Q39205782-21E2B710-47FE-4776-B8D2-9F53C41F91C4Q39448361-421199E7-1252-43C8-ABF9-84A948940D9EQ40256906-6D595855-FD03-4789-894C-B2D1CAB82328Q41396331-24926EE0-7303-4509-8CC8-410667A3D139Q41879369-AE558F0A-58A5-42E3-B8E2-F936793317BAQ42225243-A1444F78-98CC-494A-B64C-F4C55BD1A877Q43561078-9F0113DF-744E-4621-8CFA-B2983736D8D5Q44411766-5AE1A2C5-1934-4F29-BEBD-AF0AAF83CA2EQ46118162-68F7C3E7-F816-495C-8AFC-410FC3E8AC13Q47104483-C7323DE7-8B20-476D-AAC7-265727133F33Q47143835-1A743D37-9EFF-464F-A3EF-4078A627BA60Q52666822-EC223D4C-5F65-4665-986A-3E8FB1AE5943Q54266360-3A6C4D11-2E27-43E7-ABD5-ED6C876E68FFQ54984770-18E177B8-2760-4692-8778-B4A5CE94C0A0Q55286765-6534D452-0F15-4F3A-9EDC-5909749A0573Q59135403-490C1BD7-58E8-4E39-BDD5-506E979E4A43
P2860
Molecular pathology of non-small cell lung cancer: a practical guide.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Molecular pathology of non-small cell lung cancer: a practical guide.
@ast
Molecular pathology of non-small cell lung cancer: a practical guide.
@en
Molecular pathology of non-small cell lung cancer: a practical guide.
@nl
type
label
Molecular pathology of non-small cell lung cancer: a practical guide.
@ast
Molecular pathology of non-small cell lung cancer: a practical guide.
@en
Molecular pathology of non-small cell lung cancer: a practical guide.
@nl
prefLabel
Molecular pathology of non-small cell lung cancer: a practical guide.
@ast
Molecular pathology of non-small cell lung cancer: a practical guide.
@en
Molecular pathology of non-small cell lung cancer: a practical guide.
@nl
P2860
P3181
P356
P1476
Molecular pathology of non-small cell lung cancer: a practical guide.
@en
P2093
Marshall CB
P2860
P304
P3181
P356
10.1309/AJCPFR12WJKCEEZZ
P407
P577
2012-09-01T00:00:00Z